Accessibility: Skip TopNav
Survival probability in first-line BPDCN patients who received ELZONRIS (12mcg/kg/day) in Stages 1, 2 and 3
Survival probability in first-line BPDCN patients who received ELZONRIS (12mcg/kg/day) in Stages 1, 2 and 3
Format
JPEG
Source
Stemline Therapeutics, Inc.
Downloads
Original
Large
Medium
Small